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BD-2 and BD-3 increase skin flap 
survival in a model of ischemia and 
Pseudomonas aeruginosa infection
Diogo Casal  1,2,3,4, Inês Iria3,4,8,9, José S. Ramalho4, Sara Alves5, Eduarda Mota-Silva6, 
Luís Mascarenhas-Lemos1,5, Carlos Pontinha  1,5, Maria Guadalupe-Cabral4,  
José Ferreira-Silva5, Mário Ferraz-Oliveira5, Valentina Vassilenko  6, João Goyri-O’Neill1, 
Diogo Pais1 & Paula A. Videira  3,4,7
The main aim of this work was to study the usefulness of human β-defensins 2 (BD-2) and 3 (BD-3), 
which are part of the innate immune system, in the treatment of infected ischemic skin flaps. We 
investigated the effect of transducing rat ischemic skin flaps with lentiviral vectors encoding human 
BD-2, BD-3, or both BD-2 and BD-3, to increase flap survival in the context of a P. aeruginosa infection 
associated with a foreign body. The secondary endpoints assessed were: bacterial counts, and biofilm 
formation on the surface of the foreign body. A local ischemic environment was created by producing 
arterialized venous flaps in the left epigastric region of rats. Flaps were intentionally infected by 
placing underneath them two catheters with 105 CFU of P. aeruginosa before the surgical wounds were 
hermetically closed. Flap biopsies were performed 3 and 7 days post-operatively, and the specimens 
submitted to immunohistochemical analysis for BD-2 and BD-3, as well as to bacterial quantification. 
Subsequently, the catheter segments were analyzed with scanning electron microscopy (SEM). Flaps 
transduced with BD-2 and BD-3 showed expression of these defensins and presented increased flap 
survival. Rats transduced with BD-3 presented a net reduction in the number of P. aeruginosa on the 
surface of the foreign body and lesser biofilm formation.
Multi-resistant bacteria are on the rise all over the world, leading many to proclaim an imminent post-antibiotic 
era, in which common infections and surgeries could become life threatening conditions1–4. For instance, several 
authors have shown that a leg ulcer lasting for one month will have on average at least one isolated multi-drug 
resistant organism at that time5. Hence, it comes as no surprise that multiple new strategies to tackle bacterial 
infections are actively being sought1–4,6 and alternatives to conventional antibiotics are direly needed7.
In this context, antimicrobial peptides (AMPs) become particularly appealing as a new way to target one of the 
last “Achilles’ heels” of bacteria4,6,8–14. AMPs are small cationic peptides that have pleotropic bactericidal effects. 
They are divided in multiple chemical classes, of which the most studied and populated are the cathelicidins, the 
defensins, the histatins, and the dermcidins6. Defensins have been indicated as one of the most promising AMP 
classes for potential therapeutic used based on in vitro essays14–16. Defensins, similarly to other AMPs, act mainly 
by disrupting the structure of gram-positive and gram-negative bacterial cell membrane. These AMPs also inhibit 
bacterial DNA replication, transduction and translation, disturbing bacterial homeostasis (Supplementary Fig. 1). 
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The resulting byproducts trigger the activation of the complement system and inflammatory processes that fur-
ther help clearing bacterial infections (Supplementary Figs 1 and 2)8,11,17. Moreover, it has been shown that due to 
its peculiar action in the cell membrane, seldom are bacteria able to develop resistance to defensins6,18,19.
Defensins, of which 15 isoforms are currently identified in humans, are remarkably widely secreted in multiple 
epithelia, leucocytes and platelets (Supplementary Fig. 2)15,20,21. Apart from their role in the innate immunity, 
it has been recognized that they are instrumental in immune regulation and to initiate, mobilize, and amplify 
acquired immunity6.
Among the most commonly encountered multi-resistant bacteria, Pseudomonas aeruginosa stands out as one 
of the major culprits of nosocomial infections worldwide, being associated with significant morbidity, mortality, 
and increased health costs. P. aeruginosa frequently causes antibiotic-refractory infections of prosthetic mate-
rial, due to its ability to produce biofilms, and to its intrinsic, acquired and adaptive resistance mechanisms to 
multiple antibiotics2,22,23. Noteworthy, P. aeruginosa is known to thrive in poorly perfused tissues, as in ischemic 
wounds or limbs, such as those of many diabetic patients, as well as in chronic wounds and/or around prosthetic 
material5,7,24,25.
Although numerous AMPs have shown microbicidal activity against P. aeruginosa in vitro17,26–28, as far as 
the authors could determine, there are no studies using β-defensins (BDs) to treat P. aeruginosa infections in in 
vivo models27,28. This is unfortunate, since BDs have shown to be efficient against multi-resistant P. aeruginosa in 
vitro27,28. Moreover, amongst BDs, BD-2 has been shown to be particularly effective against other Gram-negative 
bacteria and some fungi, although relatively less potent against Gram-positive bacteria. Furthermore, BD-3 
is reportedly a powerful antimicrobial agent with a broad range of activity toward yeast, Gram-negative and 
Gram-positive bacteria, including the vancomycin-resistant Enterococcus faecium26,27.
Despite these interesting in vitro results, there are several reports postulating that defensins, being cationic, 
probably have hampered bactericidal activity in vivo due to the presence of neutralizing anionic compounds in 
living tissues27,29,30.
Hence, the main aim of this work was to study the usefulness of transducing an ischemic skin flap in the rat 
with two human BDs (BD-2 and BD-3) to increase flap survival in the context of a P. aeruginosa infection asso-
ciated with a foreign body. The secondary endpoints assessed were: reduction in bacterial counts, reduction in 
biofilm formation, and increase in rat survival rates. Interestingly, we observed that BD-2 and BD-3 increased 
skin flap survival in our model. Moreover, rats transduced with BD-3 presented a net reduction in the number of 
P. aeruginosa on the surface of the foreign body and lesser biofilm formation.
Materials and Methods
Figures 1 and 2 summarize the experiments done in this work.
Figure 1. Diagram illustrating the experimental groups used in this work. In all groups, flaps were 
intravascularly injected with a 100-µl solution of recombinant rat Vascular Endothelial Growth Factor-A that 
was left to act for 90 min. In the NaCl group, before closing the surgical wounds, one milliliter of a 0.9% sodium 
chloride solution was instilled under the flap into the vicinity of the silicone catheter segments. In the PA group, 
one milliliter of a 0.9% sodium chloride solution containing 105 CFU Pseudomonas aeruginosa was instilled 
under the flap into the vicinity of the silicone catheter segments. In the GFP, BD-2, BD-3 and BD-2 + BD-3 
groups, besides the procedure described for the PA group, a solution containing a lentivirus coding for Green 
fluorescent protein, human β-defensin 2, human β-defensin 3 and human β-defensins 2 and 3 was injected in 
the flap’s vessels, respectively.
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Bacterial growth. All bacteria were inoculated in Luria-Bertani (LB) broth and grown at 37 °C on a rotary 
shaker at 250 rpm, overnight. Exceptions were performed and are properly indicated.
Plasmids production. Competent Escherichia coli DH5α were transformed by heat-shock with pMD2.G and 
psPAX vectors, while competent E. coli Stbl3 were transformed with pLenti6.BD-2 and pLenti6.BD-3. Posteriorly, 
bacteria were grown in LB media, at optimal temperature in ampicillin presence, at 37 and 30 °C, respectively.
Pseudomonas aeruginosa – infection model. P. aeruginosa CECT 110+ strain (also known as P. aeruginosa 
ATCC® 10145™, which is widely used for antibiotic testing and for microbiological assays since 1947) was used 
to infect rats31–33. This strain was grown until the mid-exponential phase and it was serially diluted in 0.01 M PBS 
at a OD600nm of 0.0001 corresponding to 1.0 × 105 CFU/ml. At all times, to confirm P. aeruginosa CFUs (colony 
forming units), spreadings of bacteria were performed in LB agar dishes and colonies were counted after over-
night incubation at 37 °C.
Before performing the antimicrobials assays in the animal model of ischemia, tests were conducted to deter-
mine the ideal bacterial concentration. The concentrations initially used were: 103; 104; 105; 106 and 107 CFU/ml. 
We selected the concentration of 105 CFU/ml, since this concentration systematically resulted in clinically signifi-
cant surgical site infection and partial flap necrosis in our model. Higher concentrations led to complete or nearly 
complete flap necrosis (106 CFU/ml; n = 2) and animal’s death (107 CFU/ml; n = 3), whereas lower concentrations 
(103 and 104 CFU/ml; n = 3 for each concentration) did not produce clinically recognizable infection.
Lentivirus preparation. The defensin beta 4 A (DEFB4A) and defensin beta 103 A (DEFB103A) cDNA 
sequences, which code for the BD-2 and BD-3 proteins, respectively, were synthetized by GenScript Corporation® 
(New Jersey, USA) and cloned into pcDNA ENTR BP, using XhoI/EcoRI (DEFB4A) and SalI/KpnI (DEFB103A). 
This expression vector was generated by inserting a polylinker, previously chemically synthetized, containing 
several restriction sites into pcDNA6.2 GW/Em-GFP, a mammalian expression Gateway® (Invitrogen) previ-
ously digested with DraI/XhoI. The defensins coding sequences were transferred into pLenti6 (Invitrogen®) by 
LR recombination34.
Lentivirus particles were produced according to ViraPower™ Lentiviral Expression Systems (ThermoFisher®) 
recommendations, using HEK293FT cells (InvitrigenTM, ThermoFisher®, R700-07). Recombinant BD-2 and 
BD-3 expression in HEK293 was confirmed by RT-PCR. The total RNA of cells lines was extracted using the 
Figure 2. Diagram illustrating the main steps in the production of the rodent model of ischemia, Pseudomonas 
aeruginosa infection associated with a foreign body, lentiviral delivery of antimicrobial peptides, and evaluation 
of tissue necrosis. (A) Plasmid production by using transformed Escherichia coli (E. coli). (B) Lentivirus 
construction using HEK293FT cells. From (C1) to (C7) the steps involved in the production of a model of 
foreign body infection associated with an ischemic fasciocutaneous flap are depicted. (D) Flap biopsies were 
collected on the third and seventh day postoperatively to quantify bacteria. (E) Flap survival and perfusion was 
assessed by clinical inspection (E1) and with resort to direct infrared thermography (E2) and to histological 
analysis (F). (G) Bacterial numbers and distribution on the surface of foreign bodies retrieved 7 days 
postoperatively were determined using scanning electron microscopy. (H) Flap transduction with the human 
β-defensin 2 (BD-2) and/or β-defensin 3 (BD-3) genes was evaluated by immunohistochemical evaluation of 
flap biopsies 3 and 7 days after surgery. VEGF, Vascular Endothelial Growth Factor.
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GenElute™ Mammalian Total RNA Miniprep Kit (Sigma-Aldrich®), according to the manufacturer’s instruc-
tions. In order to remove any genomic DNA contamination, a RNase-Free DNase Set (Qiagen®) was used. The 
SuperScript® III First-Strand Synthesis System (Invitrogen™) was used to perform the reverse transcription, 
following the manufacturer’s instructions. PCR amplification was performed using primers for the genes of BD-2 
and BD-3 (Supplementary Table 1).
Ethics statement. All procedures involving animal subjects were approved by the Institutional Animal Care 
and Use Committee and Ethical Committee at our institution (08/2012/CEFCM). All in vivo studies involv-
ing rats were carried according or exceeding the recommendations in the Guide for Proper Conduct of Animal 
Experiments and Related Activities in Academic Research and Technology35.
Animals. One hundred and two male adult Wistar rats weighing 250 to 350 grams were used.
Of the 102 operated rats, 19 died in the immediate postoperative period (<24 hours), and were not included in 
the study. The following number of rats was included in each experimental group: 12 in the NaCl control group; 
13 in the P. aeruginosa group; 14 in the GFP group; 15 in the BD-2 transduced group; 15 in the BD-3 transduced 
group, and 14 in the BD-2 + BD-3 transduced group. There were no statistically significant differences between 
the different experimental groups regarding survival throughout the experiment.
All the animals were housed under standard environmental conditions and given nothing by mouth six hours 
before surgical procedures. No antibiotic prophylaxis was given.
Rats were anesthetized with a mixture of ketamine (5 mg/kg) and diazepam (0.25 mg/kg) given intraperi-
toneally. The depth of anesthesia was evaluated by toe pinch and by observance of respiration rate throughout 
the entire procedure36–39. Supplementary doses of the anesthetic mixture were provided throughout the surgical 
procedures as needed40. An ophthalmic gel was applied over the anterior surface of the eyes to avoid corneal abra-
sion. The hair over the ventral surface of the abdomen was removed with a depilatory cream (Veet®). After hair 
removal, the depilatory cream was cleaned from the abdomen with warm saline. After shaving the abdomen and 
placing the animals on the operation table, body temperature was recorded with a rectal thermometer and the 
rats were kept on a heating pad (Skaldo, Ardes ™), in order to maintain a constant body temperature. A substan-
tial amount of an alcoholic solution (Cutasept F®, Hartmann™) was sprayed over the operative site. The product 
was left in the operative site for at least 15 seconds. Application was repeated 3 times. After the last application, 
the disinfectant solution was left in contact with the operating field for at least 2 min before proceeding with the 
surgery. All surgical procedures were performed in strict sterility conditions.
Surgical Model. Succinctly, a variant of the rat abdominal arterialized venous flap was used as model of 
ischemic flap (Fig. 2)41,42. This flap was transduced with an ex vivo infusion of a 100 µl solution containing approx-
imately 4.7 × 109 plaque-forming-units of recombinant lentiviruses coding for Green Fluorescent Protein (GFP) 
or BD-2 and/or BD-343,44. This model was combined with an adapted version of the rat foreign body infection 
model (Figs 1 and 2)45.
In all animals, under a surgical operating microscope, a 5 cm long and 3 cm wide fasciocutaneous flap was 
raised on the left side of the rat’s abdomen42. Cranially, the flap was connected exclusively to the skeletonized 
lateral thoracic vein46. This vein was temporarily clamped. Caudally, the superficial caudal epigastric artery was 
ligated with an 8/0 Nylon suture. The superficial caudal epigastric vein (SCEV) was cannulated with a 27-gauge 
ophthalmic cannula (BD Bioscience™). It was then perfused with a 100-µl solution whose composition varied 
amongst the experimental groups (Figs 1 and 2). In all cases the solution contained 5 µg of recombinant rat 
Vascular Endothelial Growth Factor A (VEGF; Immunotools®) in DMEM, in order to increase transduction 
efficiency43. The composition of the solution injected in the flap’s venous system was as follows: NaCl Group 
(VEGF); PA Group (VEGF); GFP Group (VEGF + GFP coding lentivirus); BD-2 Group (VEGF + BD-2 coding 
lentivirus); BD-3 Group (VEGF + BD-3 coding lentivirus); BD-2 + BD-3 Group (VEGF + BD-2 + BD-3 coding 
lentivirus) (Fig. 1). After injection, SCEV was immediately clamped for 90 min, in order to leave the injected 
solution in contact with the flap’s vascular system43.
Subsequently, vascular clamps were removed and the SCEV was arterialized by connecting it to the femoral 
artery. In order to achieve this, the SCEV was cut from the femoral vein with a 1-mm long cuff of adjacent femoral 
vein tissue. The ostium in the femoral vein was closed with a continuous Nylon 11/0 suture. The same suture line 
was used to perform a side-to-end arteriovenous anastomosis between the SCEV and the ventral flank of the 
femoral artery through a 1-mm long ostium previously created in the latter vessel. Interrupted stitches were used 
for this anastomosis. The lateral thoracic vein was preserved cranially to ensure outflow from this arterialized 
venous flap42.
Two 1-cm segments of sterile 14-gauge silicone catheters (Mediplus™) were placed in the central aspect of 
the surgical wound. Surgical wounds were closed with a running 5/0 Nylon suture. Just before closing the lateral 
aspect of the skin wound, 1-ml of a 0.9% sodium chloride solution was instilled under the flap into the vicinity 
of the silicone catheter segments using an 18-gauge silicone catheter (Mediplus™). In all groups except the NaCl 
group, the latter solution contained 105 CFU of P. aeruginosa. The running suture was closed immediately after 
injection, in order to avoid any spilling to the area adjacent to the flap (Fig. 2).
No anticoagulants or antibiotics were administered pre, intra or postoperatively. All surgical procedures were 
performed by the same surgeon (D.C.), in order to minimize inter-surgeon variability.
Thermography. One hour after flap reperfusion, with the rat still under anesthesia, the rat’s abdomen was 
submitted to infrared thermography with a FLIR® E6 camera placed 25 cm above the abdomen. This evaluation 
intended to confirm the flap’s relative ischemia compared to the contralateral side42. Rats were placed on their 
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backs for 10 min prior to this evaluation. Thermographic measurements were made at a constant room tempera-
ture (22 °C) and humidity (50%)42,47.
Post-operative care and assessment. After thermographic evaluation was completed, a transparent 
Tegaderm™ (3 M Deustschland GmbH®) transparent film dressing was applied over the flap and adjacent skin. 
Following surgery, rats were kept in solitary rat cages and offered rat chow and water ad libitum.
Rats were assessed daily by the same blinded researcher, in order to reduce inter observer bias and variability48. 
The following parameters were evaluated: animal wellbeing, flap viability, and presence of complications.
On the third and seventh days postoperatively, rats were anesthetized as described above. Objective measure-
ment of flap survival was performed on these days based on digital photographs, which were later analyzed by a 
blinded observer using the free Image J® software40,49. The total flap area and the necrotic flap area were deter-
mined for each flap. The necrosis rate for each rat was defined by the proportion of the total flap area that was 
occupied by the necrotic flap area, being expressed as a percentage of the total flap surface area50.
After disinfecting the rat’s abdomen as detailed above, on the third postoperative day, a sample measuring 
approximately 1 cm in length and 0.5 cm in width was surgically excised from the most lateral aspect of the cau-
dal third of the viable flap. These specimens were subjected to histological analysis, as well as bacterial counts by 
both culture and real-time PCR. The integumentary defect created by the biopsy was submitted to hemostasis 
and closure with a continuous 5/0 Nylon suture taking part of the integumentary redundancy in this region. A 
transparent Tegaderm™ (3 M Deustschland GmbH®) transparent film dressing was again applied over the flap 
and adjacent skin.
On the seventh day after the first surgery, the lateral aspect of the flap was elevated, thus exposing the underly-
ing catheter segments. These were then carefully removed, taking care not to touch the rat’s skin and immediately 
immersed in the fixative solution.
The flap was then removed for histological analysis, as well as bacterial counts by culture and real-time PCR 
(Supplemental Tables 2 and 3).
Rats were euthanized on the seventh postoperative day by exsanguination under general anesthesia after cut-
ting the common carotid arteries and the external jugular veins51.
Evaluation of flap transduction by fluorescence microscopy. Four rats were submitted to the proce-
dures described above for the GFP group with the exception that no bacteria were instilled. Seven days after the 
surgery, the skin flap was harvested, fresh-frozen and observed under the fluorescence microscope. Two rats were 
submitted to an analogous the procedure, but no lentiviruses were used to transduce the flaps in these animals. 
Fluorescence microscopy images were obtained in the same manner, using the same image acquisition parame-
ters, by two blinded observers.
Quantification of BD-2 and BD-3 expression by quantitative real-time PCR. Total RNA from 
flap biopsies weighing (45–50 mg) collected on the 7th day postoperatively was extracted using the GenEluteTM 
Mammalian Total RNA Miniprep Kit (Sigma-Aldrich). The RNase-Free DNase Set (Qiagen®) was used to elim-
inate genomic DNA, according to the manufacturer’s instructions. RNA concentrations were measured and 
only samples with A260/A280 ratios between 1.8 and 2.1 were considered further. Five hundred nanograms of 
total RNA was reverse transcribed with random primers using the High Capacity cDNA Reverse Transcription 
Kit (Applied BiosystemsTM), according to the manufacturer’s instructions. Real-time PCR was performed in a 
Rotor-Gene 6000 (Corbett Life Science) using TaqMan® Fast Universal PCR Master Mix (Applied BiosystemsTM) 
[Supplemental Table 2]. Each reaction was performed in triplicate. Thermal cycling conditions were 95 for 20 sec-
onds followed by 55 cycles of 95 for 3 seconds and 60 for 30 seconds. The gene expression was normalized to 
the endogenous control β-actin, which is known to have significant basal expression52. Gene relative expression 
was calculated using the 2−ΔCT × 1000 formula, an adaptation of the 2−ΔΔCt method described by Livak and 
Schmittgen53–55. This allowed us to calculate the number of mRNA molecules of the gene of interest per 1000 
molecules of the endogenous control (β-actin).
Viable bacterial cell counts. Biopsies were collected in sterility and cut in small pieces (between 0.05 and 
0.10 mm of maximum diameter). Next, they were macerated in 0.9%(w/v) NaCl (Merck®) at 100 mg/mL concen-
tration for 5 min with a Pellet pestle (Sigma-Aldrich®). Serial dilutions were performed from the supernatant in 
0.9%(w/v) NaCl (between 10−1 and 10−5) and were spread on LB dishes in duplicated. The dishes were incubated 
at 37 °C during 14 h followed by quantification of CFUs. The CFUs counted were verified by running a series of 
tests, namely, Gram stain (Merck®); MacConkey growth (Carl Roth®) and Oxidase test (BioMérieux®) according 
to the manufacturers’ instructions.
To certify the inoculation dose of P. aeruginosa, the effective average bacterial inoculation dose under the flap 
was determined by bacterial growth and found to be (9.735 ± 0.120) X 104 CFU, which was similar to the initial 
inoculation concentration of 105 CFU/ml. There were no statistically significant differences between the initial 
bacterial inoculum in the different experimental groups.
P. aeruginosa quantification by real-time PCR. Biopsies were collected in sterility, were immediately 
immersed in RNAlater® (Sigma-Aldrich®), and incubated overnight at 4 °C. On the following day, the biopsies 
were cut in small pieces (between 0.05 and 0.10 mm) and stored at −80 °C.
Forty-five to 50 mg of excised tissue was used to extract genomic DNA by NZY Tissue gDNA Isolation Kit 
(Nzytech®) according to the manufacturer’s instructions.
To quantify P. aeruginosa, universal primers were used for 16 S rDNA (Supplementary Table 3)56. The 
real-time PCR was performed using Applied Biosystems 7500 real-time PCR System (Thermo Fisher Scientific®). 
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The reaction mixture (10 µl) contained 2x SYBR Green PCR Master Mix (Thermo Fisher Scientific®), 0.1 nmol/µl 
of forward and reverse primers each and 5 ng/µl of P. aeruginosa gDNA.
Thermo-cycling program was 40 cycles of 95 °C for 20 s, 60 °C for 30 s and 72 °C for 40 s with an initial cycle 
at 50 °C for 2 min and 95 °C for 10 min. Next, a dissociation curve was performed at 95 °C for 15 s and a range 
between 60 to 95 °C.
Histological processing. Flap biopsies were collected from the lateral aspect of the surgical flap of the rat 
3 and 7 days postoperatively, as described above. Specimens were incubated in 10% (v/v) Formalin. After par-
affinization (VWR®), specimens were cut on a microtome (Leica®) as 3 µm thick slices. These slices were stained 
with Hematoxylin-Eosin (HE) and Masson’s Trichrome (MT), according to the manufacturers’ indications57,58. 
For immunohistochemical staining with anti-BD-2 and -BD-3, slices were prepared in an analogous fashion, 
although they were cut 4 µm thick.
Immunohistochemistry processing for BD-2 and BD-3. Imunohistochemistry was performed by BenchMark 
ULTRA - Automated IHC/ISH slide staining system (Ventana®, Roche®). Summarily, the slides were heated at 
80 °C for 15 min, deparaffinized with EZ prep (Ventana®, Roche®) for 8 min. Antigen retrieval was performed 
with an ULTRA CC2 (Ventana®, Roche®) at 95 °C for 8 min (for BD2 staining) and ULTRA CC1 (Ventana®, 
Roche®) at 95 °C for 20 min (for BD3 staining). Endogenous peroxidase was blocked with 3% (v/v) Hydrogen 
Peroxide (UltraView Universal DAB Inhibitor, Ventana®, Roche®) for 4 min. The following primary monoclonal 
antibodies were used at 37 °C: anti-BD-2 (β-defensin 4 (L13-10-D1): sc-59496; Santa Cruz Biotechnology, inc.®) 
[1:50] for 40 min; and anti-BD-3 (BD-3 human (SRP4524), Sigma Aldrich®) [1:2], for 32 min. Amplification 
was accomplished with the UltraView Universal HRP Multimer (Ventana®, Roche®) for 8 min. Revelation was 
performed with the UltraView Universal DAB Chromogen and the UntraView Universal DAB H2O2 for 8 min 
(Ventana®, Roche®) followed by intensification with the UltraView Universal DAB Copper (Ventana®, Roche®) 
for 4 min. The nuclear contrast was performed with Hematoxylin and Bluing (Ventana®, Roche®) for 4 min each.
Finally, the slides were washed in water and detergent, dehydrated with increasing concentrations of ethanol 
(75, 90 and 99% (v/v)) for 1 min each, cleared in Xylene (VWR®) and mounted with synthetic mounting medium 
(Quick-D M-Klinipath®).
Catheter processing for SEM. The catheters were introduced in mounting pins to incubate at 4 °C, over-
night in a solution of 2%(v/v) Glutaraldehyde (Sigma-Aldrich®) in 0.05 M Sodium Phosphate Buffer (pH = 7.4) 
(Merck®) to fixate the specimens. Catheters were washed 3 times in 0.15 M Sodium Phosphate Buffer (pH = 7.4). 
Post fixation was performed in a solution of 1%(v/v) Osmium Tetroxide (Sigma®) in 0.12 M Sodium Cacodylate 
Buffer (pH = 7.4) (Merck®) during 2 h at room temperature. The catheters were rinsed in deionized water and 
were dehydrated in increasing concentrations of ethanol for analysis (10, 25, 40, 60, 95, 100%) (Merck®) for 
20 min for each incubation. Next, they were maintained in Acetone Pro-Analise (Merck®) overnight. Critical 
Point (Polaron® E3100) was executed within a range of pressure and temperature of 78–80 Bar and 28–30 °C, 
respectively. Three purges using CO2 (Gains®) were performed with an interval of 1 h between each. SPI 
Flash-Dry™ Silver Paint (SPI Supplies®) was used to mount the catheters to the stubs (Agar Scientific®). Catheters 
were metalized (Polaron® SC502) with Gold in the presence of Argon (Airliquide®) at a pressure between 1 and 
4 Pa and a current of 0.015 A. Four metallization cycles were performed. The specimens were examined with two 
scanning electron microscopes: a JEOL JSM-5410, with acceleration voltage of 0.015–0.030 V, for quantification 
purposes, and a JEOL JSM-7001F, with acceleration voltage of 0.015–0.030 V, for obtaining high quality images 
of selected specimens.
Histological and immunohistochemistry analysis. Each sample was independently reviewed by two 
blinded researchers. HE and MT staining were used to evaluate epidermolysis and necrosis. BD-2 and BD-3 
expression was semi quantitatively assessed by a staining intensity score (0, negative; 1, weak; 2, moderate; 3, 
strong) in the skin and perivascular regions59. When differences were found, specimens were again reviewed by 
the two researchers until a consensus was reached.
Quantification of bacteria and leucocytes on the surface of the foreign body by scanning elec-
tron microscopy. Bacteria, leucocytes and phagocytes were identified on the surface of catheters as described 
by van Gennip et al., Polliack and Saint-Guillain et al., respectively60–62. Only catheters collected from rats that 
had survived the entire experiment (7 days) were used for counting purposes. Average bacterial density on the 
surface of the catheter was based on manual counting bacteria in 20 random SEM fields at a 7500X magnification 
on each of the two catheter segments in each rat by a blinded researcher. When only one catheter segment could 
be retrieved, average bacterial density was done analogously using 40 random SEM fields at 7500X magnification. 
When more than 300 bacteria were found in a given SEM field, bacteria were considered uncountable. Using the 
same methodology, the disposition of bacteria in each SEM field was recorded as planktonic, biofilm or mixed.
Average leucocyte density on the surface of the catheter was performed in a similar fashion, with the excep-
tion that SEM fields used were obtained at 750X magnification. The average phagocyte density on the surface of 
catheters was determined in the same way. Phagocytes were defined as those leucocytes that showed evidence of 
pseudopods in direct contact with bacteria and/or biofilm.
Bacteria and leucocyte were included in counts only if the top upper edge of the cell was in the SEM field63,64. 
SEM fields with clots or largely occupied by biofilms were discarded, as bacteria were not accessible to counting 
using the methodology employed.
Statistical analysis. Qualitative variables were expressed as percentages. Quantitative variables were 
expressed as means ± standard deviation. The SPSS 21.0 ® software was used for descriptive and inferential 
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statistical analysis. The Kolmogorov-Smirnov test was used to assess if variables were normally distributed. 
ANOVA and t-Student test were used to compare averages in normally distributed data. Kruskal-Wallis and 
Mann-Whitney tests were used to compare means in non-normally distributed data. Wilcoxon rank-sum test 
was used to compare ordinal data. Proportions were analyzed with the Chi-square test or Fisher’s exact test. 
Association between numerical variables was assessed using Pearson’s correlation coefficient. Relationship 
between ordinal variables was evaluated with resort to Spearman Rank Correlation Coefficient65,66. Differences in 
survival in the different experimental groups was tested with the log rank test. A two-tailed p < 0.05 was consid-
ered to be statistically significant.
Results
Inoculation of arterialized venous flaps results in a model of persistent ischemic flap infection. 
In order to obtain a rat model of ischemia and P. aeruginosa infection in the presence of a foreign body, we fol-
lowed the steps summarized in Fig. 2. Ischemia was obtained by using a variant of the rat abdominal arterialized 
venous flap, established by our group42. Infection was obtained by inoculating P. aeruginosa and two 1-cm seg-
ments of sterile 14-gauge silicone catheters were used to simulate foreign body.
Serial P. aeruginosa concentrations (103; 104; 105; 106 and 107 CFU/ml) were tested in the mentioned model. 
A target concentration of 105 CFU/ml was selected, since it caused no rat mortality within 7 days and systemati-
cally resulted in clinically significant infection and partial flap necrosis. Higher concentrations led to complete or 
nearly complete flap necrosis (106 CFU/ml; n = 2) and animal’s death (107 CFU/ml; n = 3), whereas lower concen-
trations (103 and 104 CFU/ml; n = 3 for each concentration) did not produce identifiable infection.
By thermography analysis, one hour after surgery, the average difference between the flap surface’s temper-
ature and the temperature of the surface of the homologous contralateral region was 2.34 ± 1.06 °C (p < 0.001). 
Figure 3 shows the typical thermographic appearance of the flap one hour after surgery, illustrating the lower 
temperature of the flap compared to the contralateral side. Throughout the experiment, the flap’s temperature 
remained inferior to that of the homologous contralateral region.
Overall our data shows that a model of ischemia, infection and foreign body can be successfully obtained by 
adapting our previous established model of the rat abdominal arterialized venous flap, following inoculation with 
P. aeruginosa and introduction of silicone catheters.
BD-2 and BD-3 increase flap survival rates. We then assessed whether overexpression of BDs in the 
flaps could improve survival and reduce infection. For this purpose, we performed a set of experiments in rats 
that included flaps’ transduction with lentiviruses containing the BD-2 and BD-3 genes, as represented in Figs 1 
and 2.
To confirm transduction efficiency, seven days after surgery, flaps from rats transduced with GFP were ana-
lyzed by fluorescence microscopy. As shown in Fig. 4, flaps from GFP lentivirus-transduced rats showed GFP 
expression. The expression was greater in endothelia and in the epidermis (Fig. 4). Quantification of BD-2 mRNA 
expression by real-time PCR seven days after transduction, revealed 591.12 × 106% ± 894.00 × 106% relative 
expression of BD-2 in transduced flaps versus 3.53 × 106% ± 11.35 × 106% relative expression in non-transduced 
flaps (p = 0.014) (Fig. 4). Analogously, the relative BD-3 expression determined in a similar fashion was 
253.09 × 106% ± 354.61 × 106% in transduced flaps and 25.94 × 106% ± 87.44 × 106% for non-transduced flaps 
(p = 0.018) (Fig. 4). Using the same methodology, no statistically significant differences were found in the relative 
expression of BD-2 in the BD-2 and in the BD-2 + BD-3 groups, nor in the relative expression of BD-3 in the 
BD-3 and in the BD-2 + BD-3 groups.
Figure 5 summarizes the main clinical, optical microscopy and SEM findings in the different exper-
imental groups. On the third postoperative day, the average area of necrotic flap was higher in the P. 
Figure 3. Representative direct infrared thermography image of the ventrolateral aspect of the abdomen of the 
rat 1 hour postoperatively. Flap boundaries are highlighted with the interrupted lines. This image illustrates that 
the temperature of the flap’s surface is inferior to the contralateral side, due to the flap’s relative ischemia, which 
results from its unconventional pattern of perfusion. CT, rat’s core temperature.
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aeruginosa (61.98% ± 18.52%) and GFP (67.39% ± 20.67%) groups than in the groups BD-2 (37.16% ± 9.04%), 
BD3 (17.79% ± 5.48%) and BD-2 + BD-3 (35.09% ± 9.43%) (p ≤ 0.001). The necrotic area was the smallest in the 
NaCl (11.07% ± 5.72%) and in the BD-3 groups. There was no statistically significant difference between these 
two groups (p = 0.836) (Fig. 6).
On the seventh postoperative day, lower average flap necrosis rates were also found in the NaCl 
(20.88% ± 9.94%), BD-2 (42.81% ± 13.56%), BD-3 (25.39% ± 8.50%) and BD-2 + BD-3 (49.97% ± 11.37%) 
groups than in the P. aeruginosa (74.30% ± 16.43%) and GFP (82.53% ± 19.73%) groups (p < 0.001). Although 
slightly higher, the average necrosis rates of groups BD-2 and BD3 was not significantly different from that of 
the NaCl group. However, the average necrosis rate of BD-2 + BD-3 was higher than that of the NaCl group 
(p = 0.049) (Fig. 6).
In summary, our results demonstrate that transduction of flaps with BD-2 or BD-3 improves infected flap 
survival at day 7 following surgery, by decreasing tissue necrosis.
Evidence of flap ischemia and defensin expression by histology and immunohistochemis-
try. Histological analysis of the flaps revealed signs of venous congestion, marked edema, epidermolysis and 
areas of necrosis in all experimental groups. However, these changes were more pronounced in the P. aeruginosa 
and GFP groups (Fig. 5). Immunohistochemistry confirmed expression of BD-2 and BD-3 in the transduced rats 
(Fig. 5). BD-2 expression occurred mainly in endothelia and perivascular tissues, although it was also observed 
in fibroblasts and in the epidermis. BD-3 expression was strongest in the epidermis and skin appendages (Fig. 5). 
Using the mentioned semi-quantitative score for immunohistochemistry staining59, BD-2 expression was as fol-
lows: 0.25 ± 0.45 for the NaCl group; 0.23 ± 0.44 for the PA group; 0.36 ± 0.50 for the GFP group; 2.07 ± 0.59 
for the BD-2 group; 0.13 ± 0.35 for the BD-3 group; 1.64 ± 0.50 for the BD2 + BD-3 group. Proceeding in a 
similar way, BD-3 expression in the different experimental groups was the following: 0.67 ± 0.49 for the NaCl 
group; 0.69 ± 0.48 for the PA group; 0.79 ± 0.70 for the GFP group; 0.27 ± 0.59 for the BD-2 group; 2.80 ± 0.41 
for the BD-3 group; 2.50 ± 0.52 for the BD2 + BD-3 group. BD-3 expression was stronger than BD-2 expression. 
However, this difference did not reach statistically significance.
BD-2 and BD-3 decrease bacterial numbers and biofilms on the surface of foreign bodies. We 
then assessed the number of bacteria on the surface of the foreign body in the different experimental groups. 
At the end of the experiment, it was possible to retrieve 56 catheters that were distributed as follows: 8 in the 
NaCl group, 6 in the PA group, 12 in the GFP group, 9 in the BD-2 group, 11 in the BD-3 group, and 10 in the 
BD-2 + BD-3 group.
In all rats, infection was confirmed by growth in P. aeruginosa MacConkey agar, Gram stain and positive 
oxidase reaction. Table 1 summarizes bacterial counts determined by different methods on the 7th day postoper-
atively in the different experimental groups.
For each rat, the average number of bacteria on the surface of catheters was based on manual counting bacterial 
cells on 20 SEM fields at 7500X magnification on each of the two catheter segments, or, when only one catheter 
Figure 4. Confirmation of flap transduction. (A to D) Typical fluorescence image photographs of the skin and 
hypodermis of the flap of a rat transduced with a Green Fluorescent Protein coding lentivirus (LV-GFP) and 
those of the flap of a non-transduced rat (Control) seven days after surgery. These photographs demonstrate 
transduction of flaps by the virus. Calibration bar = 100 µm (E). Analysis of the BD-2 and BD-3 mRNA 
expression in rat flaps. Box plots represent the relative mRNA expression level of human β-defensins 2 and 
3 (BD-2 and 3) analyzed in transduced flaps (BD-2, BD-3 and BD-2 + BD-3) compared to non-transduced 
flaps on the seventh post-operative day relatively to the expression of the β-actin in these flaps using real-time 
PCR. The relative mRNA levels of each gene are expressed as the percentage of the β-actin mRNA levels. Flaps 
transduced with BD-2 include the BD-2 and the BD-2 + BD-3 groups. Similarly, flaps transduced with BD-3 
include the BD-3 and the BD-2 + BD-3 groups. Horizontal lines in the upper portion of the figure indicate 
statistically significant differences between groups (p < 0.05).
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segment could be retrieved, on counts performed on 40 SEM fields of that catheter segment. A scanning electron 
microscope JEOL JSM-5410, with acceleration voltage of 0.015–0.030 V, was used for quantification purposes.
Values are expressed as average ± standard deviation.
CFU, colony forming units; SEM, Scanning electron microscopy
As shown in Table 1, significant differences were found in the number of bacteria on the surface of the foreign 
body (Fig. 7). The number of bacteria on the surface of catheters was lower in the NaCl, BD-3, and BD-2 + BD-3 
groups. There were no statistically significant differences between these 3 groups. The BD-3 group presented a 
smaller number of bacteria on the surface of catheters than the P. aeruginosa (p < 0.042), GFP (p < 0.001) and 
BD-2 (p = 0.035) groups.
Concerning the distribution of bacteria on the surface of catheters (Figs 5E to J’, 8 to 10), the NaCl group 
presented the largest percentage of SEM fields without bacteria (42.81% ± 28.36%; p < 0.001), followed by the 
BD-3 group (12.72% ± 17.87%), the BD-2 group (6.39% ± 12.32%), and the BD-2 + BD-3 group (2.75% ± 6.17%) 
(Fig. 10). The percentage of SEM fields without evidence of biofilm formation were also more numer-
ous in the NaCl (99.06% ± 1.86%), BD-2 (74.44% ± 22.63%), BD-3 (88.59% ± 12.40%), and BD-2 + BD-3 
(73.50% ± 17.72%) groups compared to the control groups P. aeruginosa (50.83% ± 23.06%) and GFP 
(39.38% ± 25.30%). This difference in biofilm presence of the former four groups compared to the GFP control 
group was statistically very significant (p ≤ 0.002) (Fig. 10).
Numerous leucocytes could be observed on the surface of catheters in all groups. (Figs 5Y to D’, 7 and 11). 
Apart from the average number of leucocytes being superior in the GFP group (4.92 ± 3.68 leucocytes/SEM field) 
than in the NaCl group (0.75 ± 0.93 leucocytes/SEM field; p = 0.016), no other statistically significant differences 
were found in leucocytes’ and phagocytes’ numbers on the surface of catheters in the remaining experimental 
groups (Fig. 7).
Figure 5. Typical macroscopic and microscopic features of flaps in the different experimental groups. 
Macroscopic images were taken on the third day post-operatively (D3 Post-op), and seven days post-operatively 
(D7 Post-op). Microscopic images were taken with immunohistochemical staining with anti-BD-2 (BD-2 IH), 
or anti-BD-3 (BD-3 IH) antibodies of flap biopsies performed on the seventh day after the surgery. Scanning 
electron microscopy images (SEM) of the surface of catheters were taken at 750X or 7500X amplification. 
Figures (Y to D’) show the typical aspect of leucocytes on the surface of foreign bodies. In figures (E’ to J’) 
the characteristic features of bacteria on the surface of foreign bodies using the magnifications employed for 
counting purposes are illustrated. Calibration bar = 100 µm (M,N, P–T, V–X); 25 µm (O, U); 10 µm (Y–D’); 
1 µm (E’–J’).
1 0Scientific RepoRts |          (2019) 9:7854  | https://doi.org/10.1038/s41598-019-44153-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
Bacterial contamination with cocci were observed in 8.92% ± 22.21% of SEM fields (Fig. 9). There were no 
statistically significant differences between the different experimental groups.
Overall, data shows that in the model used the surface of foreign bodies presents significant numbers of bac-
teria. Flap transduction with either BD-2 or BD-3, and in particular with the latter, remarkably lowers bacterial 
numbers on the surface of foreign bodies.
Figure 6. Bar graphs representing the percentage of flap necrosis relatively to the flap original surface area on 
the third (A) and seventh (B) postoperative days in the different experimental groups. Horizontal lines in the 
upper portion of the figure indicate statistically significant differences between groups (p < 0.05). Error bars 
indicate 95% confidence intervals. **p < 0.01. ***p < 0.001.
Experimental Group
Viable bacteria cultured from skin 
flap biopsy (CFU/mg)
Real-time PCR from skin flap 
biopsy (ng/µl)
Bacteria on the surface of the 
foreign body (n/SEM field)
NaCl 2.42 × 105 ± 5.87 × 105 1.23 × 10−5 ± 2.06 × 10−5 7.74 ± 8.18
PA 6.98 × 106 ± 1.17 × 107 1.26 × 10−1 ± 1.17 × 107 71.70 ± 47.4
GFP 9.46 × 105 ± 6.46 × 105 7.22 × 100 ± 1.36 × 101 92.75 ± 35.9
BD-2 8.06 × 105 ± 8.59 × 105 5.52 × 10−1 ± 7.97 × 10−1 67.08 ± 42.4
BD-3 2.51 × 105 ± 5.88 × 105 1.13 × 10−5 ± 1.39 × 10−5 19.37 ± 16.3
BD-2 + BD-3 3.55 × 105 ± 4.52 × 105 1.94 × 10−3 ± 2.92 × 10−3 54.04 ± 41.6
Statistical analysis summary No significant differences were found No significant differences were found NaCl < PA; p = 0.013
NaCl < GFP; p < 0.001
NaCl < BD-2; p = 0.010
PA > BD-3; p = 0.042
GFP > BD-3; p < 0.001
BD-2 > BD-3; p = 0.035
Table 1. Average values of bacterial counts determined by different methods on the 7th day postoperatively in 
the different experimental groups. For each rat, the average number of bacteria on the surface of catheters was 
based on manual counting bacterial cells on 20 SEM fields at 7500X magnification on each of the two catheter 
segments, or, when only one catheter segment could be retrieved, on counts performed on 40 SEM fields of that 
catheter segment. A scanning electron microscope JEOL JSM-5410, with acceleration voltage of 0.015-0.030 
V, was used for quantification purposes. Values are expressed as average ± standard deviation. CFU, colony 
forming units; SEM, Scanning electron microscopy.
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Bacterial counts and biofilms on the surface of the foreign body were correlated with flap necrosis. 
We then assessed whether bacteria accumulation on the surface of the foreign body was correlated with flap 
necrosis. Table 2 synthetizes the most relevant correlations in the data obtained in this study.
Flap necrosis rates on the 3rd and 7th day postoperatively were highly correlated (Pearson’s correlation fac-
tor = 0.922; p < 0.001). Flap necrosis was also correlated with several features of catheters’ surface. In fact, flap 
necrosis rate on the third postoperative day was positively correlated with the average number of bacteria per 
SEM field and the percentage of SEM fields with biofilm (Pearson’s correlation factor = 0.609; p < 0.001 and 
0.596; p < 0.001, respectively). It was negatively correlated with the following variables: percentage of SEM fields 
with planktonic bacteria; percentage of SEM fields without bacteria; percentage of SEM fields without biofilm 
(Pearson’s correlation factor = - 0.409, p = 0.004; - 0.426, p = 0.003 and - 0.681; p < 0.001, respectively).
Analogously, flap necrosis on the seventh day postoperatively was positively correlated with the following 
findings: average number of bacteria per SEM field (Pearson’s correlation factor = 0.626; p < 0.001) and the per-
centage of SEM fields with biofilm (Pearson’s correlation factor = 0.563; p = 0.001). Moreover, flap necrosis rate 
on the seventh day after surgery was significantly negatively correlated with the percentage of SEM fields with 
planktonic bacteria, without bacteria and without biofilm (Pearson’s correlation factor = - 0.379, p = 0.03; - 0.462, 
p = 0.007; - 0.674, p < 0.001, respectively).
The average number of bacteria per SEM field was also positively correlated with the number of leuco-
cytes (Pearson’s correlation factor = 0.276; p = 0.041); and phagocytes per SEM field (Pearson’s correlation fac-
tor = 0.401; p = 0.002).
P. aeruginosa counts on the 3rd postoperative day determined by culture of flap biopsies, were correlated with 
flap necrosis on that day (Pearson’s correlation factor = 0.287; p = 0.041) and on the seventh day after surgery 
(Pearson’s correlation factor = 0.395; p = 0.016) (Fig. 12). However, there were no statistically significant correla-
tions between P. aeruginosa counts after flap biopsy on the seventh day after surgery and flap necrosis either on 
the 3rd or 7th postoperative days. (Fig. 12).
There were no statistically significant correlations between bacterial quantification after flap biopsy and cul-
ture or real-time PCR, on the one hand, and SEM bacterial counts on the other hand.
In conclusion, our data shows that the bacterial counts on the surface of the foreign body and biofilm forma-
tion were correlated with flap necrosis.
Discussion
Our study showed that transducing an ischemic skin flap in the rat with human β-defensins, the BD-2 and BD-3 
genes, increased skin flap survival in the context of a P. aeruginosa infection in the presence of a foreign body. 
In addition, BD-2 and particularly BD-3 transduction reduced P. aeruginosa numbers and biofilm formation on 
the surface of the foreign body. Other authors had already shown that BD-2 and BD-3 are overexpressed in the 
presence of P. aeruginosa keratitis in mice and that overexpression was associated with diminished P. aeruginosa 
numbers in the eyes of affected mice15,67.
However, as far as the authors could determine, this is the first description of the transduction of BDs genes to 
treat a P. aeruginosa infection in vivo14. It is also the first time that the transduction of an AMP gene is performed 
Figure 7. Bar graphs representing the average number of bacteria, leucocytes and phagocytes on the surface 
of the catheter segments placed underneath the flaps per scanning electron microscopy (SEM) field. For each 
rat, the average number of bacteria on the surface of catheters was based on manual counting bacterial cells 
on 20 SEM fields at 7500X magnification on each of the two catheter segments, or, when only one catheter 
segment could be retrieved, on counts performed on 40 SEM fields of that catheter segment. Average leucocyte 
and phagocyte density on the surface of the catheter was performed in a similar way, with the exception that 
SEM fields used were at obtained 750X magnification. A scanning electron microscope JEOL JSM-5410, with 
acceleration voltage of 0.015–0.030 V, was used for quantification purposes. Horizontal lines in the upper 
portion of the figure indicate statistically significant differences between groups (p < 0.05). Error bars indicate 
95% confidence intervals. ***p < 0.001.
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with the intent to treat an infection taking place in a poorly perfused region, simulating local ischemia. This sce-
nario is frequent in the clinical setting, occurring after trauma, radiotherapy or in ischemic regions of the body, 
namely in the lower limbs of atherosclerotic and/or diabetic patients68,69. This study describes for the first time 
the morphometric features of the bacteria on the surface of a foreign body and thoroughly compares them with 
the clinical evaluation of the overlying skin flap, and with bacterial quantification using microbiological cultures 
of skin biopsy and real-time PCR. Other authors had already shown the possibility of treating a Staphylococcus 
aureus infection transducing a normally perfused flap with the AMP cathelicidin LL-3743.
The groups treated with BDs presented a smaller percentage of SEM fields with any form of biofilm relatively 
to the GFP group (p ≤ 0.002; Fig. 10). Arguably, the GFP group seems to be the most appropriate control group, as 
it involves expression of a foreign protein using a viral vector. This alone has been shown to affect local bacterial 
clearance70. These data suggest that in vivo these AMPs are able to prevent the formation of biofilms, which are one 
of the most common causes of clinical persistent infection71–76. This adds to the knowledge of BD physiology, as 
most papers in this field refer to the action of AMPs in vitro, not addressing the role of these substances in vivo77.
Flap necrosis rates on the 3rd and 7th day postoperatively were highly correlated (Pearson’s correlation fac-
tor = 0.922; p < 0.001). This suggests that, in this rodent model, the ongoing P. aeruginosa infection associated 
with the foreign body led to continuous breakdown of the overlying integument72. This had already been amply 
observed in clinical practice72,78. Recently, it has been shown that P. aeruginosa induces the production and release 
of cytotoxic amyloids with prion features79,80. It would be interesting to investigate in future studies whether this 
mechanism plays a significant role in the model used in the present work, and whether these processes could be 
curtailed or even halted by BDs transduction.
Interestingly, in this work, flap necrosis was significantly correlated with several features of catheters’ surface, 
namely bacterial numbers and biofilm presence. In opposition, in the present study, flap necrosis rates in the 
different groups was not correlated with bacterial determination by real-time PCR of flap biopsies. Moreover, 
only bacterial counts of microbiological cultures of biopsies of the flap performed on the third post-operative day 
correlated, and even then, only poorly, with flap necrosis rates on the third (Pearson’s correlation factor = 0.287; 
p = 0.041) and seventh (Pearson’s correlation factor = 0.395; p = 0.016) days after surgery. This lends support to 
the notion that in bacteria capable of producing biofilms, such as P. aeruginosa, the protracted release of bacterial 
cells from the biofilm medium is one of the main determinants of continuous tissue damage to the overlying 
Figure 8. Morphological features of bacteria on the surface of the foreign body in increasing magnifications 
by scanning electron microscopy. (A,B) Flat biofilm on the surface of a catheter segment. (C) Magnification 
of the large rectangular area in the center of (B) showing Pseudomonas aeruginosa and associated biofilm. (D) 
Magnification of the small rectangular area in the center of (B) showing Pseudomonas aeruginosa bacterial 
cells dividing in the biofilm. (E) Mushroom-shaped biofilm with uncountable bacterial cells. (F) Higher 
magnification view of the rectangular dotted area in the center of (E) showing bacterial division and adherence 
to the surface of the catheter (arrow heads). (G) Biofilm covering most of P. aeruginosa cells. (H) High 
magnification view of a P. aeruginosa cell dividing on the surface of the catheter. (I) High magnification image 
of a single P. aeruginosa cell on the surface of the biofilm showing the irregularities of the bacterial wall surface. 
Calibration bar = 100 µm (A) 10 µm (B,E) 1 µm (C,D,F,I).
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Figure 10. Bar graphs representing the proportion of scanning electron microscopy (SEM) fields in the 
different experimental groups with no bacteria, with planktonic bacteria, with both planktonic bacteria and 
biofilm, and only with biofilm. For each rat, observations were made on 20 random SEM fields at 7500X 
magnification on each of the two catheter segments, or, when only one catheter segment could be retrieved, 
on 40 random SEM fields of that catheter segment. Horizontal lines in the upper portion of the figure indicate 
statistically significant differences between groups (p < 0.05). Error bars indicate 95% confidence intervals. 
**p < 0.01, ***p < 0.001.
Figure 9. Typical scanning electron microscopy images of the surface of catheters showing the variable 
distribution of bacteria. (A) Pseudomonas aeruginosa in the planktonic form; (B) P. aeruginosa are seen 
forming a large flat biofilm in the central portion of the image; (C) Small cocci (contamination) are seen on the 
surface of an hair shaft that contaminated the surgical wound; the box represents an higher amplification view 
of the middle portion of the hair shaft (D) P. aeruginosa cells are seen scattered on the surface of the catheter; 
some of these cells are dividing; amongst P. aeruginosa, it is possible to observe cocci; (E) Diplococcus; (F) 
Staphylococcus. Calibration bar = 1 µm (A, D, E, F); 10 µm (B,C)
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tissues45,60,72–74. In fact, a recent meta-analysis demonstrated that biofilms are present in more than three quarters 
of chronic wounds, increasing their extension or preventing their closure73.
All these data suggest that the model herein used adequately mimics clinically relevant skin ulcers and infec-
tions. Noteworthy, a similar model had already been described by Van Wijngaerden et al., who introduced a 
catheter in the back of the rat to test antibiotic efficacy45. Furthermore, other authors, have also placed a catheter 
under a well perfused flap in the groin region of the rat43. Notwithstanding, these authors did not use SEM to 
evaluate the surface of the catheter used as a foreign body. It was only recently that van Gennip et al. emphasized 
the potential advantages of studying the morphology and interaction of bacteria and immune cells on the surface 
of foreign bodies with SEM60. However, these latter authors placed the foreign body inside the peritoneal cavity60.
We believe that our model presents the additional advantage of simulating an ischemic environment sur-
rounding the foreign body. In fact, as shown in Fig. 5, one hour after surgery, the average temperature difference 
between the flap and the contralateral side was 2.34 ± 1.06 °C (p < 0.001). These data confirm that the surgical 
skin flap placed over the foreign body was ischemic, since skin temperature is known to be proportional to integ-
umentary perfusion81.
In all groups, a 100 µl solution was injected intravascularly. To ensure that the same number of viral particles 
was administered in each of the transfected groups, in the BD-2 + BD-3 group, the solution was composed of 50 µl 
of the solution used in the BD-2 group and 50 µl of the solution used in the BD-3 group. The BD-2 + BD-3 group 
did not show statistically significant differences relatively to either the BD- 2 or the BD-3 groups, regarding flap 
necrosis on 7th post-operative day (Fig. 6), in the number of bacteria (Fig. 7) or bacterial distribution on the sur-
face of the foreign body (Fig. 10). Hence, these data suggest that the simultaneous expression of the two defensins 
does not have a synergistic or an antagonistic effect82.
One of the limitations of the present methodology was the impossibility to precisely differentiate between 
leucocytes types (Fig. 11)60,83–87. Although immunological methods have been proposed to distinguish leucocyte 
types using SEM, it has been shown that these methods may significantly affect leucocyte adhesion and morphol-
ogy, making interpretation of data difficult88. In future works, it would be interesting to characterize with other 
techniques leucocyte numbers and cell types both on the surface of the foreign body and in the surrounding 
tissues.
Figure 11. Typical scanning electron microscopy images of the surface of catheters showing multiple features 
of leucocyte morphology and interaction with the surrounding environment. (A) Low magnification view of the 
surface of the catheter showing giant leucocytes interspersed with smaller leucocytes. (B) Leucocyte engulfing 
a Pseudomonas aeruginosa cell in the area highlighted with the interrupted line box; on the top right corner 
of the picture there is a higher amplification view of this interaction. (C) Leucocyte adhering to the catheter’s 
surface. (D) A leucocyte phagocytosing a region with biofilm. (E,F) leucocytes interacting on the surface of the 
catheter (dotted boxes highlight amplified views of these interactions). (G) Large leucocyte engulfing adjacent 
biofilm. (H) In the central portion of the image there is a large leucocyte extending a pseudopod into adjacent P. 
aeruginosa. (I) Three leucocytes with multiple vesicles on their surface. Calibration bar = 100 µm (A) 1 µm (B) 
10 µm (C to I).
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Another limitation of this study was the presence of contamination of the wound by bacteria other than P. 
aeruginosa, namely by cocci, in 8.92 ± 22.21% of SEM fields (Fig. 9). This contamination affected all experimental 
groups equally. It is no doubt related to the ischemic nature of the skin flap used, leading to partial flap necro-
sis, surgical wound dehiscence and contamination with saprophytic flora. Hence, studies similar to this one but 




correlation factor P value
Flap necrosis rate on the 3rd 
postoperative dayFlap necrosis 
rate on the 7th postoperative day
Flap necrosis rate on the 7th day 0.922 p < 0.001
Average number of bacteria per SEM field 0.609 p < 0.001
Percentage of SEM fields with biofilm 0.596 p < 0.001
Percentage of SEM fields with planktonic bacteria −0.409 p = 0.004
Percentage of SEM fields without bacteria −0.426 p = 0.003
Percentage of SEM fields without biofilm −0.681 p < 0.001
P. aeruginosa counts on the 3rd postoperative day 
determined by culture of flap biopsies 0.287 p = 0.041
Average number of bacteria per SEM field 0.626 p < 0.001
Percentage of SEM fields with biofilm 0.563 p = 0.001
Percentage of SEM fields with planktonic bacteria −0.379 p = 0.03
Percentage of SEM fields without bacteria −0.462 p = 0.007
Percentage of SEM fields without biofilm −0.674 p < 0.001
P. aeruginosa counts on the 3rd postoperative day 
determined by culture of flap biopsies 0.395 p = 0.016
Average number of bacteria per 
SEM field
Average number of leucocytes per SEM field 0.276 p = 0.041
Average number of phagocytes per SEM field 0.401 p = 0.002
Table 2. Synthesis of the most relevant correlations in the data obtained in this study. SEM, scanning electron 
microscopy.
Figure 12. Graphic representation of the relation between the proportion of flap necrosis (expressed as 
percentage of flap’s initial area) and bacterial counts after flap biopsy on the third (A) and seventh (B) days after 
surgery in the different experimental groups. On the both days, flap necrosis and bacterial counts were lower in 
the animals expressing human β-defensins 2 and 3. Error bars indicate 95% confidence intervals.
1 6Scientific RepoRts |          (2019) 9:7854  | https://doi.org/10.1038/s41598-019-44153-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
The authors must concede that multiple other delivery methods of the BDs genes could have been 
employed89,90. Many of the other available vectors have potential advantages and disadvantages. For example, it 
has been shown that intradermal delivery of the transgenes might be superior to intravascular perfusion using 
lentivirus vectors in skin flaps91. Consequently, further studies are also necessary in this field, namely to test the 
superiority of other vectors, as well as the susceptibility of other bacteria species, particularly bacteria resistant to 
conventional antibiotics. Furthermore, it would be interesting to assess if BDs could be used to reverse established 
biofilm on the surface of foreign bodies.
Although the potential clinical merits of AMPs have been extoled for the past two decades, their clinical 
application has been tardy and incipient, due to potential systemic toxicity, susceptibility to proteases, and high 
cost of peptide production10,11,13,14,92,93. However, despite several in vitro studies (Supplemental Figs 1 and 2) many 
questions remain to be answered regarding the in vivo mechanisms of BD-2 and BD-3 bacterial clearance, biofilm 
impediment and increased tissue survival. The present work provides little help in answering these questions, 
making further studies warranted4,14,20,94.
Finally, the authors would like to note that controlled local production of a specific AMP by a flap placed 
over a difficult wound (for example, osteomyelitis in a mangled extremity) may theoretically allow to eradicate a 
bacterial infection and thus permit wound closure43. If the introduction of the AMP sequence was to cause onco-
genesis, the flap could be simply removed and replaced by another flap or eventually by a skin graft43,95.
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